C. Bachmeyer et al., HYPOMAGNESEMIC AND HYPOCALCEMIC COMA, CON VULSION AND EYE-MOVEMENT DISORDERS AFTER CHEMOTHERAPY WITH PLATINUM COMPOUNDS, La Revue de medecine interne, 17(6), 1996, pp. 467-469
We describe a case of neurologic manifestations including coma, convul
sion and eye movement disorders, associated with hypomagnesemia and hy
pocalcemia in a patient treated with cisplatine for an ovarian adenoca
rcinoma. Pathophysiological mechanisms involve renal tubular damage le
nding to renal magnesium wasting and related hypocalcemia.